Cytomegalovirus in the etiopathogenesis of schizophrenia and suicide risk: A case-control study

被引:0
|
作者
Akgul, Ozer [1 ]
Demirel, Omer Faruk [2 ]
机构
[1] Istanbul Aydin Univ, Tip Fak, Tibbi Mikrobiyol Anabilim Dali, Istanbul, Turkey
[2] Istanbul Univ Cerrahpasa, Cerrahpasa Tip Fak, Ruh Sagligi & Hastaliklari Anabilim Dali, Istanbul, Turkey
来源
JOURNAL OF PSYCHIATRIC NURSING | 2020年 / 11卷 / 02期
关键词
INFECTION; BIPOLAR; METAANALYSIS; INDIVIDUALS; ASSOCIATION; VIRUSES; IMMUNE;
D O I
10.14744/phd.2020.27167
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objectives: The aim of this case-control study is to investigate the possible relationship between Cytomegalovirus (CMV) infection and schizophrenia or suicidal behavior. Methods: A total of 274 individuals, including 134 patients with schizophrenia and 140 healthy controls were included in this case-control study. Sociodemographic characteristics, clinical data and suicidal risk scores of the participants were recorded during face to face interviews, and serum CMV IgG seroprevalence was determined. Results: The demographic and clinical data of the participants included in the study were as follows: the mean age was 30.82±0.59 years; 50.7% were female and 49.3% male; 5.1% were illiterate, 26.3% were primary school graduates, 42.3% were secondary middle school graduates, 26.3% were undergraduates; the mean Suicide Behaviors Question-naire-Revised (SBQ-R) score was 6.27±3.12. Seropositivity rate of CMV IgG was found to be 64.6% (177/274). It was determined that CMV IgG seropositivity rates were 48.6% (68/140) in the healthy control group and 81.3% (109/134) in the schizophrenia group, and the relationship between schizophrenia and CMV IgG seropositivity was statistically significant (p<0.001). CMV IgG seropositivity rates were 61.5% in the non-suicide risk and 70.7% in the suicide risk group, and the relationship between CMV IgG seropositivity and suicide risk was not statistically significant (p=0.137). Conclusion: The potential effects of latent CMV infection on dopamine and other neurotransmitter levels may play a role in the etiopathogenesis of schizophrenia. Nevertheless, further studies on CMV and schizophrenia are needed and may lead to improved treatments for schizophrenia. © 2020 by Journal of Psychiatric Nursing.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 50 条
  • [1] Medication and suicide risk in schizophrenia: A nested case-control study
    Reutfors, Johan
    Bahmanyar, Shahram
    Jonsson, Erik G.
    Brandt, Lena
    Boden, Robert
    Ekbom, Anders
    Osby, Urban
    SCHIZOPHRENIA RESEARCH, 2013, 150 (2-3) : 416 - 420
  • [2] Risk factors for suicide in patients with schizophrenia: nested case-control study
    Rossau, CD
    Mortensen, PB
    BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 355 - 359
  • [3] Suicide Ideation and Behavior as Risk Factors for Subsequent Suicide in Schizophrenia: A Nested Case-Control Study
    Clapham, Eric
    Boden, Robert
    Brandt, Lena
    Jonsson, Erik G.
    Bahmanyar, Shahram
    Ekbom, Anders
    Osby, Urban
    Reutfors, Johan
    SUICIDE AND LIFE-THREATENING BEHAVIOR, 2019, 49 (04) : 996 - 1005
  • [4] Suicide risk and antipsychotic side effects in schizophrenia: nested case-control study
    Reutfors, Johan
    Clapham, Eric
    Bahmanyar, Shahram
    Brandt, Lena
    Jonsson, Erik G.
    Ekbom, Anders
    Boden, Robert
    Osby, Urban
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2016, 31 (04) : 341 - 345
  • [5] IS OCD AT RISK FOR SUICIDE? A CASE-CONTROL STUDY
    Maina, Giuseppe
    Salvi, Virginio
    Tiezzi, Maria
    Albert, Umberto
    Bogetto, Filippo
    CLINICAL NEUROPSYCHIATRY, 2007, 4 (03): : 117 - 121
  • [6] Risk assessment and suicide by patients with schizophrenia in secondary mental healthcare: a case-control study
    Lopez-Morinigo, Javier-David
    Ayesa-Arriola, Rosa
    Torres-Romano, Beatriz
    Fernandes, Andrea C.
    Shetty, Hitesh
    Broadbent, Matthew
    Dominguez-Ballesteros, Maria-Encarnacion
    Stewart, Robert
    David, Anthony S.
    Dutta, Rina
    BMJ OPEN, 2016, 6 (09):
  • [7] Suicide Risk and Side Effects from Antipsychotics in Schizophrenia: A Nested Case-Control Study
    Reutfors, Johan
    Bahmanyar, Shahram
    Brandt, Lena
    Clapham, Eric
    Joensson, Erik G.
    Boden, Robert
    Ekbom, Anders
    Osby, Urban
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 333 - 333
  • [8] Suicide in schizophrenia: A retrospective case-control study of 51 suicides
    Sinclair, JMA
    Mullee, MA
    King, EA
    Baldwin, DS
    SCHIZOPHRENIA BULLETIN, 2004, 30 (04) : 803 - 811
  • [9] Completed suicide in schizophrenia: Evidence from a case-control study
    Pompili, Maurizio
    Lester, David
    Grispini, Alessandro
    Innamorati, Marco
    Calandro, Fulvia
    Iliceto, Paolo
    De Pisa, Eleonora
    Tatarelli, Roberto
    Girardi, Paolo
    PSYCHIATRY RESEARCH, 2009, 167 (03) : 251 - 257
  • [10] Risk factors for completed suicide in schizophrenia and other chronic psychotic disorders: A case-control study
    McGirr, A.
    Tousignant, M.
    Routhier, D.
    Pouliot, L.
    Chawky, N.
    Margolese, H. C.
    Turecki, G.
    SCHIZOPHRENIA RESEARCH, 2006, 84 (01) : 132 - 143